Phase II/III randomized clinical trial of individualized adaptive radiotherapy guided by radiosensitivity (RAPART) in locally advanced non-small cell lung cancer patients

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: e12079841c83878787c6873baf8f5c3efe061d49
First added on: Apr 08, 2025